Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
BMJ Global Health|July 23, 2020
Delivery of sexual and reproductive health interventions in conflict settings: a systematic reviewMariella Munyuzangabo, Dina Sami Khalifa, Michelle F Gaffey, et al.
Crohn'S & Colitis 360|September 9, 2022
Treatment Patterns and Standardized Outcome Assessments Among Patients With Inflammatory Conditions of the Pouch in a Prospective Multicenter RegistryEdward L Barnes, Parakkal Deepak, Poonam Beniwal-Patel, et al.
Journal of Crohn'S & Colitis|June 27, 2025
ECCO Topical Review on Pouch DisordersMaia Kayal, Gabriele Bislenghi, Michel Adamina, et al.
Digestive Diseases and Sciences|June 24, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision-MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.
Diseases of the Colon and Rectum|September 25, 2021
Slow and Steady Wins the Race: A Solid Case for a 3-Stage Approach in Ulcerative ColitisMichael C Plietz, Maia Kayal, Anam Rizvi, et al.
Research Square|April 27, 2026
Navigating Treatment Selection in Acute Severe Ulcerative Colitis: A Prospective Mixed Method Analysis of Factors Influencing Patient Decision MakingReid Herran, Samuel Wilcox, Gal Hodish, et al.
The American Journal of Gastroenterology|June 25, 2025
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the PouchEdward L Barnes, Laura Raffals, Taha Qazi, et al.
BMJ Global Health|April 9, 2021
Delivering nutrition interventions to women and children in conflict settings: a systematic reviewShailja Shah, Zahra Ali Padhani, Daina Als, et al.
Pancreas|March 10, 2018
Predictors of Progression Among Low-Risk Intraductal Papillary Mucinous Neoplasms in a Multicenter Surveillance CohortValerie Gausman, Pujan Kandel, Priscilla A Van Riet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2019
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel DiseasesJordan E Axelrad, Ahmad Bazarbashi, James Zhou, et al.
Pageof 9